1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Chromis LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 Favipiravir, Standard of Care - COVID-19 | Phase 2 / Phase 3 | Unknown | Chromis LLC | 330 | 2020-04-23 | 2020-06-16 |
COVID-19 (1)
Chloroquine (1) · Hydroxychloroquine (1) · Lopinavir (1) · Ritonavir (1) · Standard of Care (1) · favipiravir (1)
Russia (1)
Elena Pavlikova, MD,PhD,Prof (1) · Nikita Lomakin, MD,PhD (1)